NASDAQ · UFPT
UFP Technologies, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for UFPT: Nov 2, 2026
UFP Technologies, Inc. Common Stock is estimated to report earnings on 11/02/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $2.63. The reported EPS for the same quarter last year was $2.39.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $2.63 | $2.68 | $2.57 | 2 |
| Dec 2026 | $2.52 | $2.56 | $2.48 | 2 |
| Mar 2027 | $2.69 | $2.69 | $2.69 | 1 |
| Jun 2027 | $2.95 | $2.95 | $2.95 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · The Motley Fool · MarketBeat · RTTNews- Zacks · Sep 10, 3:36 AM EDTZacks Industry Outlook Highlights Veracyte, Globus Medical and UFP TechnologiesVeracyte, Globus Medical and UFP Technologies are positioned to benefit as GenAI adoption reshapes medical instruments.
- Zacks · Sep 9, 11:41 AM EDTImplied Volatility Surging for UFP Technologies Stock OptionsInvestors need to pay close attention to UFPT stock based on the movements in the options market lately.
- Zacks · Sep 9, 9:03 AM EDT3 Medical Instruments Stocks Banking on GenAI to Tackle Industry WoesGenAI offers growth potential for VCYT, GMED and UFPT, but regulatory and technology risks are likely to challenge adoption across healthcare.
- The Motley Fool · Aug 31, 5:10 PM EDTUFP Technologies Director Cynthia Feldmann Sells 1,000 SharesThe sale represents a total value of $324,260.
- MarketBeat · Aug 28, 6:01 PM EDTUFP Technologies Targets 12%-18% Growth as Medical Device M&A Pipeline BuildsSmall Caps Are Crushing the S&P 500—3 Stocks Still Worth BuyingUFP Technologies (NASDAQ:UFPT) outlined its strategy to expand through organic growth and acquisitions, emphasizing its role as a contract development and manufacturing organization serving medical-device companies.
- The Motley Fool · Aug 10, 9:48 PM EDTUFP Technologies (UFPT) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Aug 5, 4:09 AM EDTBiotech Stocks At 52-Week Highs – UFPT +25%, INFU +33%, SOPH +20% On Q2 Reports, REPL, PBLS(RTTNews) – The following biotech stocks reached a 52-week high on August 4, 2026, driven by key catalysts like positive quarterly results or certain regulatory milestones.
- The Motley Fool · Aug 4, 3:10 PM EDTWhy UFP Technologies Stock Is Skyrocketing TodayUFP Technologies grew sales and adjusted earnings per share by 15% and 17% in the second quarter.
- MarketBeat · Aug 4, 2:04 PM EDTUFP Technologies Q2 Earnings Call HighlightsSmall Caps Are Crushing the S&P 500—3 Stocks Still Worth BuyingUFP Technologies (NASDAQ:UFPT) reported second-quarter 2026 sales growth of 15.1% to $174 million, supported by broad-based demand across its medical technology portfolio, while adjusted earnings per share rose 16.8%
- RTTNews · Aug 3, 10:41 PM EDTUFP Technologies, Inc. Profit Advances In Q2(RTTNews) – UFP Technologies, Inc. (UFPT) revealed earnings for its second quarter that Increases, from last year
- Zacks · Aug 3, 6:45 PM EDTUFP Technologies (UFPT) Beats Q2 Earnings and Revenue EstimatesUFP (UFPT) delivered earnings and revenue surprises of +16.34% and +8.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- MarketBeat · Jul 22, 1:50 PM EDTSmall Caps Are Crushing the S&P 500—3 Stocks Still Worth BuyingSector rotation doesn't always mean money moving from sector to sector. In many cases, investors see capital moving from large-cap to small-cap stocks. That's precisely the shift playing out in 2026, and the numbers back it up. Through July 21, small-cap benchmarks have meaningf
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for UFP Technologies, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.